info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > CDK
CDK
Cat.No. Product Name Information Area
T4051 LDC4297 LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM. Others
T3589 NSC23005 Sodium NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting He... Others
T3186 NU2058 NU2058 is a potent CDK inhibitor that has CDK2 IC(50)=17 microM and CDK1 IC(50)=26 mi... Cancer
T3664 THZ1 THZ1 is a novel selective and potent covalent CDK7 inhibitor with IC50(binding affini... Cancer
T6924 P276-00 P276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM,... Others
T6920 ON123300 ON123300 is a potent and multi-targeted kinase inhibitor with IC50 of 3.9 nM, 5 nM, 2... Others
T6866 K03861 K03861 is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for... Others
T6837 Flavopiridol (Alvocidib) Flavopiridol (Alvocidib) competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4... Others
T3207 Briciclib Briciclib is a small molecule that suppresses cyclin D1 accumulation in cancer cells.... Other
T3195 CVT-313 CVT-313(NG-26) is a potent, selective, reversible, and ATP-competitive inhibitor of C... Cancer
T6735 XL413-hydrochloride XL413 (BMS-863233) is a potent and selective cell division cycle 7 homolog (CDC7) kin... Cancer
T6612 NU6027 NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 ... Cancer
T6563 LDC000067 LDC000067 is a highly selective CDK9 inhibitor with IC50 of 44 nM, 55/125/210/ >227/ ... Cancer
T6240 Palbociclib (PD0332991) Isethionate Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 with IC... Cancer
T6239 Palbociclib (PD-0332991) hydrochloridehot Palbociclib (PD-0332991) HCl is a highly selective inhibitor of?CDK4/6?with?IC50?of 1... Cancer
T6206 PHA-767491 PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM an... Cancer
T6205 AT7519 AT7519 is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM; less ... Cancer
T6199 LEE011 LEE011 is an orally available, and highly specific CDK4/6 inhibitor. Phase 3. Cancer
T6167 SU9516 SU 9516 is a 3-substituted indolinone CDK inhibitor with IC50 of 22 nM, 40 nM, and 20... Cancer
T6162 BS-181 hydrochloride BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 4... Cancer
T6126 JNJ-7706621 JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM... Cancer
T6081 Milciclib (PHA-848125) Milciclib (PHA-848125) is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 ... Cancer
T6049 SNS-032 (BMS-387032) SNS-032 has firstly been described as a selective inhibitor of CDK2 with IC50 of 48 n... Cancer
T3111 LY2835219 LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and ... Cancer
T2679 BMS-265246 BMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cel... Cancer
T2670 ML167 ML167 is a highly selective Cdc2-like kinase 4 (Clk4) inhibitor with IC50 of 136 nM, ... Cancer
T2653 SB1317 SB1317/TG02 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 ... Cancer
T2615 Flavopiridol Hydrochloride Flavopiridol hydrochloride competes with ATP to inhibit CDKs including CDK1, CDK2, CD... Cancer
T2517 SCH900776 MK-8776 (SCH 900776) is a selective Chk1 inhibitor with IC50 of 3 nM in a cell-free a... Cancer
T2506 AZD-5438 AZD5438 is a potent inhibitor of CDK1/2/9 with IC50 of 16 nM/6 nM/20 nM in cell-free ... Cancer
1